LFVN

LifeVantage Corporation

LifeVantage Corporation is a pioneer in Nutrigenomics - a new science dedicated to biohacking the human aging code. The Company engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and skin and hair care products, including its Protandim® product line, LifeVantage® Omega+ and ProBio dietary supplements, the TrueScience® line of Nrf2 infused skin care and hair care products, Petandim® for Dogs, Axio® smart energy drink mixes, and the PhysIQ™ weight management system. LifeVantage was founded in 2003 and is headquartered in Salt Lake City, Utah.

LifeVantage Corporation (LFVN) is rated C+ (2.7/5) on Deltasharpe Prism, scored against Consumer Defensive sector peers. Its strongest pillar is Profitability (B); its weakest is Growth (D+). The rating has held at C+ for 9 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.7 / 5.0
C+
Value
B-
Factor Score 3.0 / 5.0
Growth
D+
Factor Score 1.7 / 5.0
Profitability
B
Factor Score 3.4 / 5.0
Momentum
C+
Factor Score 2.7 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 24.0
EV / EBITDA 6.5
Rev Growth YoY -23.1%
Gross Margin 77.6%
Price Return 3M -22.7%
Price Return 12M -21.0%
Catalyst Signal 0.00
Market Cap $63.9M
TTM Revenue $182.6M
Price / Sales 0.4
ROE 14.9%

Historical Factor Score Progression

Held C+ for 9 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-13 B- (3.0) D+ (1.7) B (3.4) C+ (2.7) C+ (2.6) C+ (2.7)
2026-11-06 B (3.2) D+ (1.5) B (3.4) C+ (2.8) C (2.5) C+ (2.7)
2026-10-30 B (3.2) D (1.5) B (3.5) B (3.3) C (2.5) C+ (2.8)
2026-10-23 B (3.2) D (1.5) B (3.5) B- (3.1) C (2.3) C+ (2.7)
2026-10-16 B (3.2) D (1.5) B (3.5) B (3.3) C (2.4) C+ (2.8)
Page 1 of 3